SAFETY INFORMATION
| Signal word | Warning |
|---|---|
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H413:Hazardous to the aquatic environment, long-term hazard |
| Precautionary Statement Codes |
P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P273:Avoid release to the environment. |
COMPUTED DESCRIPTORS
| Molecular Weight | 446.9 g/mol |
|---|---|
| XLogP3 | 5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 446.1397203 g/mol |
| Monoisotopic Mass | 446.1397203 g/mol |
| Topological Polar Surface Area | 66.5 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 713 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
RELATED SUPPLIERS
SRINI PHARMACEUTICALS PVT LTD
1Y
product:7-Chloro-1-[2-methyl-4-[(2-methylbenzoyl) amino]benzoyl]-5-oxo-2,3,4,5- tetrahydro-1H-1-benzazepine. 98%